Cañendo, Lourdes Y.

HRN: 26-38-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
CEFTRIAXONE 1G (VIAL)
12/13/2024
12/20/2024
IVTT
2g
Od
Infected Wound
Waiting Final Action 
12/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/13/2024
12/20/2024
IVTT
600mg
Q6
Infected Wound
Waiting Final Action 
12/14/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/14/2024
12/21/2024
TOPICAL
1%
BID
Infected Wound
Waiting Final Action 
12/21/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/21/2024
12/28/2024
TOPICAL
25g
Bid
Infected Wound
Waiting Final Action 
12/23/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/23/2024
12/27/2024
IV
600mg
Q6
Infected Wound
Waiting Final Action 
12/23/2024
CEFTRIAXONE 1G (VIAL)
12/23/2024
12/27/2024
IV
2g
Od
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: